睪固酮替代疗法市场规模、份额、成长分析、按产品类型、按活性成分、按最终用户、按地区 - 行业预测，2024-2031 年

睪固酮替代疗法的全球市场规模预计到 2022 年约为 14 亿美元，预测期内（2024-2031 年）复合年增长率为 8.9%，高于 2023 年的 15 亿美元和 2031 年的 29 亿美元。达到10亿美元。

由于人口老化、生活方式改变和压力水平上升等因素的综合作用，导致睪固酮缺乏症增加，全球睪固酮替代疗法（TRT）市场正在显着增长。 TRT 涵盖多种产品和治疗方法，包括注射剂、凝胶剂、贴片和丸剂，以及对于准确诊断和管理低睪固酮水平至关重要的诊断测试和监测设备。睪固酮的产生自然会随着老龄化的增长而下降，导致对有效治疗方案的需求不断增长，而人口老化是一个主要驱动因素。此外，医疗保健专业人员透过诊断缺陷、制定适当的治疗方案以及确保患者安全和治疗有效性，在该市场中发挥关键作用。主导製药公司和诊所持续不断的研究和开发工作，市场正在不断发展，推出新的创新 TRT 解决方案。这种成长趋势在美国市场尤其明显，预计未来几年将维持持续的年复合成长率（CAGR）。随着对睾酮替代疗法的需求持续上升，该市场的定位是改善睾酮缺乏症患者的生活质量，这表明其对更广泛的製药和医疗领域的重要性。总体而言，TRT 市场正变得越来越重要，因为它寻求满足不断变化的人口的医疗保健需求。

目录

介绍

• 研究目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 监管分析
• 案例研究分析
• 专利分析
• 价格分析

睾酮替代疗法市场：按产品类型

• 市场概况
• 注射
• 外用
• 其他的

睪固酮替代疗法市场：依活性成分分类

• 市场概况
• 十一烷酸睪酮
• 环丙酸睪酮
• 睪固酮
• 庚酸睪酮
• 其他的

睾酮替代疗法市场：按最终用户分类

• 市场概况
• 医院
• 诊所

睾酮替代疗法市场规模：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• AbbVie Inc.
• Pfizer Inc.
• Endo International plc
• Teva Pharmaceutical Industries Ltd.
• Bausch Health Companies Inc.
• Acerus Pharmaceuticals Corporation
• Marius Pharmaceuticals
• Insud Pharma SL
• Allergan
• Hikma Pharmaceuticals PLC
• Cipla Inc.
• Sun Pharmaceutical Industries Ltd.
• Lupin Pharmaceuticals
• Novartis AG
• AstraZeneca

Global Testosterone Replacement Therapy Market size was valued at around USD 1.4 billion in 2022 and is expected to rise from USD 1.5 billion in 2023 to reach a value of USD 2.9 billion by 2031, at a CAGR of 8.9% over the forecast period (2024-2031).

The Global Testosterone Replacement Therapy (TRT) market is experiencing significant growth, driven by a confluence of factors including an aging population, lifestyle changes, and an increase in stress levels, which have all contributed to rising testosterone deficiencies. TRT encompasses a range of products and treatment modalities such as injections, gels, patches, and pellets, alongside diagnostic tests and monitoring devices essential for accurate diagnosis and management of low testosterone levels. The aging demographic is a key driver, as testosterone production naturally declines with age, leading to a greater need for effective therapy options. Additionally, healthcare professionals play a crucial role in this market by diagnosing deficiencies, prescribing suitable treatments, and ensuring patient safety and treatment efficacy. With ongoing research and development efforts spearheaded by pharmaceutical companies and clinics, the market is evolving to introduce new and innovative TRT solutions. This growth trend is underscored in the US market, which is projected to maintain a sustainable compound annual growth rate (CAGR) in the upcoming years. As the demand for testosterone replacement therapy continues to rise, the market is positioned to enhance the quality of life for individuals experiencing deficiencies, marking its significance within the broader pharmaceutical and medical sectors. Overall, the TRT market is becoming increasingly vital as it seeks to address the healthcare needs of an evolving population.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Testosterone Replacement Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Testosterone Replacement Therapy Market Segmental Analysis

Global Testosterone Replacement Therapy Market is segmented by Product Type, Active ingredients, End User, and region. Based on Product Type, the market is segmented into Injectables, Topical, and Others. Based on Active ingredients, the market is segmented into Testosterone Undecanoate, Testosterone Cypionate, Testosterone, Testosterone Enanthate, and Others. Based on End User, the market is segmented into Hospitals, Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Testosterone Replacement Therapy Market

The growing prevalence of testosterone insufficiency, especially among males aged 40 to 79, is a significant market driver for the global testosterone replacement therapy (TRT) market. With approximately 20% of men over 60 and 30% over 70 experiencing low testosterone levels, combined with an estimated 10% to 40% of the global male population affected by this condition, the demand for effective TRT solutions is surging. Additionally, the upward trajectory of the elderly demographic further compounds this need, creating increased awareness and acceptance of TRT as a viable treatment option, thereby propelling market growth and innovation in therapeutic offerings.

Restraints in the Global Testosterone Replacement Therapy Market

The global testosterone replacement therapy market faces significant restraints due to the substantial risk of various post-treatment complications, including sleep apnea, acne, gynecomastia, and heightened risk of thromboembolic events. These potential side effects deter patients and healthcare providers from pursuing treatment, thereby inhibiting market growth. Additionally, the high costs associated with testosterone therapy, coupled with the need for ongoing medical supervision and potential follow-up treatments, further limits accessibility for patients. These combined factors contribute to hesitance among both consumers and practitioners, ultimately stifling the demand and expansion of the testosterone replacement therapy market on a global scale.

Market Trends of the Global Testosterone Replacement Therapy Market

The global testosterone replacement therapy (TRT) market is experiencing a notable shift towards personalized treatment options, catering to individual patient needs. This trend has spurred the growth of compounding pharmacies that offer customizable formulations. In tandem, pharmaceutical companies are innovating delivery methods, introducing products like nasal sprays and transdermal patches to enhance treatment convenience and efficacy. Additionally, an integrated approach combining TRT with lifestyle changes is gaining traction, advocating for holistic hormone management. The rise of digital health technologies further transforms the market, with telemedicine facilitating remote consultations, while mobile apps monitor hormone levels, ultimately improving patient access and engagement in their TRT journey.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Analysis
• Case Study Analysis
• Patent Analysis
• Pricing Analysis

Testosterone Replacement Therapy Market, By Product Type

• Market Overview
• Injectables
• Topical
• Others

Testosterone Replacement Therapy Market, By Active ingredients

• Market Overview
• Testosterone Undecanoate
• Testosterone Cypionate
• Testosterone
• Testosterone Enanthate
• Others

Testosterone Replacement Therapy Market, By End User

• Market Overview
• Hospital
• Clinics

Testosterone Replacement Therapy Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endo International plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch Health Companies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acerus Pharmaceuticals Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marius Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insud Pharma S.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lupin Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments